VEA
PTLA

Virtus ETF Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Virtus ETF Advisers’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,368
Closed -$159K – 493
2020
Q1 		$159K Sell
22,368
-1,887
-8% -$23.5K 0.07% 286
2019
Q4 		$579K Sell
24,255
-2,655
-10% -$73.2K 0.09% 193
2019
Q3 		$722K Sell
26,910
-4,526
-14% -$127K 0.15% 160
2019
Q2 		$853K Buy
+31,436
New +$986K 0.18% 168
2019
Q1 		– Sell
-32,607
Closed -$636K – 295
2018
Q4 		$636K Buy
32,607
+13,746
+73% +$283K 0.11% 39
2018
Q3 		$502K Buy
18,861
+1,271
+7% +$41.5K 0.05% 123
2018
Q2 		$664K Sell
17,590
-1,613
-8% -$61.7K 0.59% 118
2018
Q1 		$627K Sell
19,203
-1,115
-5% -$48.9K 0.54% 101
2017
Q4 		$989K Buy
20,318
+11,378
+127% +$575K 1.24% 22
2017
Q3 		$483K Buy
8,940
+818
+10% +$48K 0.07% 93
2017
Q2 		$456K Sell
8,122
-7,246
-47% -$290K 0.07% 74
2017
Q1 		$602K Buy
15,368
+1,473
+11% +$46.9K 0.11% 96
2016
Q4 		$312K Buy
13,895
+4,160
+43% +$81.3K 0.09% 109
2016
Q3 		$221K Hold
9,735
– – 0.11% 132
2016
Q2 		$230K Buy
9,735
+4,503
+86% +$111K 0.17% 114
2016
Q1 		$107K Sell
5,232
-329
-6% -$10.4K 0.15% 142
2015
Q4 		$286K Buy
+5,561
New +$270K 0.79% 40

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Virtus ETF Advisers's PTLA Position: Q2 2020 in Review

Virtus ETF Advisers sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 22,368 shares — an estimated $159K sold.

Virtus ETF Advisers first reported a position in PTLA in Q4 2015 and held it in 17 quarters. The position peaked at $989K in Q4 2017. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Virtus ETF Advisers reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Virtus ETF Advisers sold 22,368 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $159K.
  • Virtus ETF Advisers first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 17 quarters.
  • Virtus ETF Advisers's Portola Pharmaceuticals, Inc. position peaked at $989K in Q4 2017.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Virtus ETF Advisers's 13F filing for Q2 2020, filed 5 Aug 2020.